Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
Open Access
- 21 May 2024
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 13 (10) , e7296
Abstract
Background: Although the incidence of double primary cancers (DPCs) involving lung cancer is rising, they have not been studied sufficiently. This study retrospectively analyzed the clinicopathological and prognostic characteristics of DPC patients with lung cancer and developed a survival nomogram to predict the individual OS rates.Methods: We included 103 DPC patients with lung cancer from Shengjing Hospital between 2016 and 2021. Based on the 6‐month cancer occurrence interval, the cases were categorized as synchronous DPCs (sDPCs) or metachronous DPCs (mDPCs). Furthermore, the mDPCs were subdivided based on whether the lung cancer occurred first (LCF cohort) or the other cancer occurred first (OCF cohort).Results: Among the patients, 35 (33.98%) and 68 (66.02%) had sDPCs and mDPCs, respectively. In the mDPCs cohort, 18 (26.47%) belonged to the LCF cohort and 50 (73.53%) to the OCF cohort. The most frequent primary cancer sites were the breast (27.18%), colorectum (22.33%), and urinary system (18.45%). Independent risk factors for progression‐free survival were Stage IV lung cancer (p = 0.008) and failure to undergo radical lung cancer surgery (p = 0.028). The risk factors for OS included squamous carcinoma (p = 0.048), Stage IV lung cancer (p = 0.001), single cancer resection plus drug therapy (p < 0.001), drug therapy alone (p = 0.002), failure to undergo radical lung cancer surgery (p = 0.014), and chemotherapy (p = 0.042). The median OS was 37 months, with 3‐ and 5‐year rates of 50.9% and 35.9%, respectively.Conclusion: DPCs involving lung cancer account for 1.11% of cases. The breast, colorectum, and urinary system were the most common extra‐pulmonary sites, and mDPCs were more frequent than sDPCs. Radical lung cancer surgery significantly affects prognosis, and drug therapy alone may be preferable when only one tumor is operable. The developed nomogram can accurately predict individual 3‐year and 5‐year OS rates.Keywords
This publication has 47 references indexed in Scilit:
- Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch SyndromeGastroenterology, 2009
- Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramThe Oncologist, 2007
- Mechanisms of therapy-related carcinogenesisNature Reviews Cancer, 2005
- International rules for multiple primary cancers (ICD-0 third edition)European Journal Of Cancer Prevention, 2005
- Second Primary Tumors Involving Non-small Cell Lung Cancer*Chest, 2005
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Risk of Secondary Leukemia After a Solid Tumor in Childhood According to the Dose of Epipodophyllotoxins and Anthracyclines: A Case-Control Study by the Société Française d’Oncologie PédiatriqueJournal of Clinical Oncology, 2003
- Multiple primary malignancies involving lung cancer—clinical characteristics and prognosisLung Cancer, 2002
- Multiple Primary Neoplasms at a Single InstitutionAmerican Journal of Clinical Oncology, 2000
- Multiple primary malignant neoplasms.I. Introduction and presentation of dataCancer, 1961